Document is current
Any future updates will be listed below
-
Authors
Wilson, Mackenzie https://orcid.org/0000-0002-3265-6579
Thavorn, Kednapa https://orcid.org/0000-0003-4738-8447
Hawrysh, Terry https://orcid.org/0000-0002-3700-8044
Graham, Ian D. https://orcid.org/0000-0002-3669-1216
Atkins, Harold https://orcid.org/0000-0002-6168-3939
Kekre, Natasha https://orcid.org/0000-0001-8394-0855
Coyle, Doug https://orcid.org/0000-0003-3492-2268
Lalu, Manoj M. https://orcid.org/0000-0002-0322-382X
Fergusson, Dean A. https://orcid.org/0000-0002-3389-2485
Chan, Kelvin K. W.
Ollendorf, Daniel A. https://orcid.org/0000-0001-6016-8129
Presseau, Justin https://orcid.org/0000-0002-2132-0703
-
Funding
Funding for this research was provided by:
Ontario Institute for Cancer Research (P.HSR.202)
BioCan RX (P.HSR.202)
- License Information
-
More Information
Article History
Accepted: 1 August 2022
First Online: 8 September 2022
Declarations
:
: The project is funded by the Joint OICR-BioCanRx Health Services Competition, grant award numbers P.HSR.202 and CSEI8.
: None to declare.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ottawa Health Science Network Research Ethics Board (REB 20200320-01HT).
: Informed consent was obtained from all individual participants included in the study.
: Patients signed informed consent regarding publishing their de-dentified data.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: JP and KT led the conceptualization of the research project. MW led the preparation of the manuscript. MW, KT, TH, IDG, HA, NK, DC, MML, DAF, KKWC, DAO, and JP contributed to the research planning and read, contributed to, and approved the final manuscript.
